Stock Events

Stock Events

VYNE Therapeutics (VYNE) Q1 2025 Earnings

6MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.3

-0.25

-0.2

-0.15

Details

Expected EPS

-0.303333

Actual EPS

-0.28

Surprise EPS

0.02

Surprise Percent

+7.69%

Description

VYNE Therapeutics (VYNE) has reported earnings of -0.28 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.